1. Newsroom
  2. Webinar – Opportunities in the Gold Mining Sector
Menu
Analisi 05.10.2020

Webinar – Opportunities in the Gold Mining Sector

Webinar – Opportunities in the Gold Mining Sector

On Thursday 1 October 2020, UBP's experts Norman Villamin and Peter Kinsella hosted a webinar with Evy Hambro, Global Head of Thematic and Sector Investing at Blackrock, to discuss what gold investors can expect in the quarters ahead.



Here is a summary of the key points presented:

  • Despite the correction of the past weeks, we continue to believe gold remains in a long-cycle bull market that should target USD 2,200/oz by end-2021 as stimulus re-accelerates in early 2021 with a prolonged period of negative real interest rates and continued USD weakness.
  • Even beyond leverage to a rising gold price, gold equity investors can benefit from increasing volumes and widening margins as input costs fall and dividends rise.
  • There are a range of gold companies that investors can get exposure to – explorers, developers and emerging, intermediate, and senior producers as well as royalty companies – to diversify their risk across the sector.

Find out more about this topic in our latest Spotlight.

Download the full report

Villamin_Norman_150x150.jpg

Norman Villamin
CIO Wealth Management

Peter_Kinsella_150x150.jpg

Peter Kinsella
Global Head of Forex Strategy


Altro da leggere

Analisi 26.11.2021

The strong performance potential of Swiss small and mid-cap equities

The Swiss small- and mid-cap (also known as “SMID-cap”) universe offers a balanced and diversified exposure to companies with long-term value-creation potential. Active managers can create significant added value through a disciplined stock-selection process.

Analisi 22.11.2021

CRISPR: the implications of gene editing

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

Analisi 19.11.2021

UBP Investment Outlook 2022

Embracing Change